20 Apr Medisonal brings a reliable source of cannabis-based medicine to the UK

Medisonal launches on May 4^th and is set to revolutionise the supply of cannabis-based medicine (CBPM) to patients across the UK, using up-to-the-minute technology to match patients with prescribing doctors.

Founding Partner Lloyd Michaels, says, “It’s all about the patient. The whole team of business professionals and medical advisors at Medisonal are passionate about making a positive impact on the lives of people who could benefit from CBPM.

“The Series A investment we’ve achieved is being used to develop the technological infrastructure through which patients can access experienced specialist prescribers and reliable information. We’re committed to making CBPM affordable, accessible and acceptable.”

He continues, “I first had the idea two years ago, when I used CBPM for pain management following an accident. After seeing high profile cases on the news of mothers who were successfully campaigning to get it via the NHS, for their children, I kept hearing more and more about it. The more I looked into it, the more I realised that patients in the UK deserved better access to this important treatment option, and doctors needed a trustworthy source of distribution.”

Medisonal’s unique set up is based on understanding the needs of both patients and prescribers, enabling them to have continuous access to the supply of CBPM and to raise awareness of its benefits. By championing further research and supporting patient lobbying groups, the company aims to make prescribed CBPM both simpler to access and more widely accepted in the UK.

Medisonal’s purpose is to position itself as more than just a distributor; ensuring a seamless and regular supply of CBPM through its network of professionals, with the dispensing handled by Centennial Pharma Services (CPS). CPS is part of the Medisonal group and is a fully licensed pharmacy. This streamlined supply chain allows Medisonal to bring CPBM to the market via a more affordable and reliable route.

Advanced technology will give doctors access to reliable, up-to-date information and support from experienced prescribers of CBPM. Patients will benefit from an informative platform, detailing both information and prescribers.